BetterScholar BetterScholar

L. Hebert

New England Journal of Medicine, Kidney International, Journal of the American Medical Association, Annals of Internal Medicine, Journal of the American Society of Nephrology, American Journal of Kidney Diseases, American Journal of Human Genetics, Journal of Clinical Investigation Show more
13
Role
Title
Level Year L/R
🐜 The classification of glomerulonephritis in systemic lupus erythematosus revisited.
23 auth. J. Weening, V. D’Agati, M. Schwartz, S. Seshan, C. Alpers, G. Appel, J. Balow, J. Bruijn, T. Cook, F. Ferrario, ... A. Fogo, E. Ginzler, L. Hebert, G. Hill, P. Hill, J. Jennette, N. Kong, P. Lesavre, M. Lockshin, L. Looi, H. Makino, L. A. Moura, Michio Nagata 		11 2004
11
🐜
🐜 Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
17 auth. J. Wright, G. Bakris, T. Greene, L. Agodoa, L. Appel, J. Charleston, D. Cheek, Janice E G Douglas-Baltimore, J. Gassman, R. Glassock, ... L. Hebert, K. Jamerson, J. Lewis, R. Phillips, R. Toto, J. Middleton, S. Rostand 		10 2002
10
🐜
🐜 Blood Pressure Control, Proteinuria, and the Progression of Renal Disease
11 auth. J. Peterson, S. Adler, J. Burkart, T. Greene, L. Hebert, L. Hunsicker, ... A. King, S. Klahr, S. Massry, J. Seifter, Modification of Diet in Renal Disease (MDRD)Study 		10 1995
10
🐜
🦁 Uric acid and cardiovascular risk.
L. Hebert, B. Rovin 		10 2009
10
🦁
🐜 The classification of glomerulonephritis in systemic lupus erythematosus revisited.
23 auth. J. Weening, V. D’Agati, M. Schwartz, S. Seshan, C. Alpers, G. Appel, J. Balow, J. Bruijn, T. Cook, F. Ferrario, ... A. Fogo, E. Ginzler, L. Hebert, G. Hill, P. Hill, J. Jennette, N. Kong, P. Lesavre, M. Lockshin, L. Looi, H. Makino, L. A. Moura, Michio Nagata 		10 2004
10
🐜
🐜 Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
44 auth. L. Agodoa, L. Appel, G. Bakris, G. Beck, J. Bourgoignie, J. Briggs, J. Charleston, D. Cheek, W. Cleveland, J. Douglas, M. Douglas, D. Dowie, M. Faulkner, Avril Gabriel, J. Gassman, ... T. Greene, Y. Hall, L. Hebert, L. Hiremath, K. Jamerson, C. Johnson, J. Kopple, J. Kusek, J. Lash, J. Lea, J. Lewis, M. Lipkowitz, S. Massry, J. Middleton, E. Miller, Keith C. Norris, D. O'Connor, A. Ojo, R. Phillips, V. Pogue, Mahboob Rahman, O. Randall, S. Rostand, G. Schulman, W. Smith, D. Thornley‐Brown, C. Tisher, R. Toto, J. Wright 		9 2001
9
🐜
🐜 Intensive blood-pressure control in hypertensive chronic kidney disease.
30 auth. L. Appel, J. Wright, T. Greene, L. Agodoa, B. Astor, G. Bakris, W. Cleveland, J. Charleston, G. Contreras, M. Faulkner, F. Gabbai, J. Gassman, L. Hebert, K. Jamerson, J. Kopple, ... J. Kusek, J. Lash, J. Lea, J. Lewis, M. Lipkowitz, S. Massry, E. Miller, Keith C. Norris, R. Phillips, V. Pogue, O. Randall, S. Rostand, M. Smogorzewski, R. Toto, Xuelei Wang 		9 2010
9
🐜
🐜 Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.
10 auth. J. Peterson, S. Adler, J. Burkart, T. Greene, L. Hebert, L. Hunsicker, ... A. King, S. Klahr, S. Massry, J. Seifter 		9 1995
9
🐜
🐜 Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).
8 auth. G. Eknoyan, T. Hostetter, G. Bakris, L. Hebert, A. Levey, H. Parving, ... M. Steffes, R. Toto 		8 2003
8
🐜
🐜 Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans.
23 auth. Yan Yang, Erwin K. Chung, Yee-Ling Wu, S. Savelli, H. Nagaraja, Bi Zhou, Maddie Hebert, Karla N. Jones, Y. Shu, K. Kitzmiller, ... C. Blanchong, K. McBride, G. Higgins, R. Rennebohm, Robert R. Rice, K. Hackshaw, R. Roubey, J. Grossman, B. Tsao, D. Birmingham, B. Rovin, L. Hebert, C. Y. Yu 		8 2007
8
🐜
🐬 Primate erythrocyte-immune complex-clearing mechanism.
J. Cornacoff, L. Hebert, W. Smead, M. E. VanAman, D. Birmingham, F. Waxman 		8 1983
8
🐬
🐜 Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
38 auth. F. Fervenza, G. Appel, S. Barbour, B. Rovin, R. Lafayette, N. Aslam, J. A. Jefferson, P. Gipson, D. Rizk, J. Sedor, J. Simon, E. McCarthy, P. Brenchley, S. Sethi, C. Avila-Casado, ... H. Beanlands, J. Lieske, David Philibert, Tingting Li, L. Thomas, Dolly F Green, L. Juncos, Lada Beara-Lasic, S. Blumenthal, Amy N. Sussman, S. Erickson, M. Hladunewich, P. Canetta, L. Hebert, N. Leung, J. Radhakrishnan, H. Reich, S. Parikh, D. Gipson, Dominic Lee, Bruno R. da Costa, P. Jüni, D. Cattran 		8 2019
8
🐜
🐒 Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.
8 auth. S. Brodsky, T. Nadasdy, B. Rovin, A. Satoskar, G. Nadasdy, Haifeng M. Wu, ... U. Bhatt, L. Hebert 		8 2011
8
🐒